Biologically optimized helium ion plans: calculation approach and its in vitro validation

Treatment planning studies on the biological effect of raster-scanned helium ion beams should be performed, together with their experimental verification, before their clinical application at the Heidelberg Ion Beam Therapy Center (HIT). For this purpose, we introduce a novel calculation approach based on integrating data-driven biological models in our Monte Carlo treatment planning (MCTP) tool. Dealing with a mixed radiation field, the biological effect of the primary (4)He ion beams, of the secondary (3)He and (4)He (Z  =  2) fragments and of the produced protons, deuterons and tritons (Z  =  1) has to be taken into account. A spread-out Bragg peak (SOBP) in water, representative of a clinically-relevant scenario, has been biologically optimized with the MCTP and then delivered at HIT. Predictions of cell survival and RBE for a tumor cell line, characterized by [Formula: see text] Gy, have been successfully compared against measured clonogenic survival data. The mean absolute survival variation ([Formula: see text]) between model predictions and experimental data was 5.3%  ±  0.9%. A sensitivity study, i.e. quantifying the variation of the estimations for the studied plan as a function of the applied phenomenological modelling approach, has been performed. The feasibility of a simpler biological modelling based on dose-averaged LET (linear energy transfer) has been tested. Moreover, comparisons with biophysical models such as the local effect model (LEM) and the repair-misrepair-fixation (RMF) model were performed. [Formula: see text] values for the LEM and the RMF model were, respectively, 4.5%  ±  0.8% and 5.8%  ±  1.1%. The satisfactorily agreement found in this work for the studied SOBP, representative of clinically-relevant scenario, suggests that the introduced approach could be applied for an accurate estimation of the biological effect for helium ion radiotherapy.

[1]  M Scholz,et al.  Track structure and the calculation of biological effects of heavy charged particles. , 1996, Advances in space research : the official journal of the Committee on Space Research.

[2]  T Kanai,et al.  Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. , 1997, Radiation research.

[3]  A. Ferrari,et al.  FLUKA: A Multi-Particle Transport Code , 2005 .

[4]  K Parodi,et al.  A Monte Carlo-based treatment planning tool for proton therapy , 2013, Physics in medicine and biology.

[5]  David J Carlson,et al.  A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy. , 2012, International journal of radiation oncology, biology, physics.

[6]  U Oelfke,et al.  A phenomenological model for the relative biological effectiveness in therapeutic proton beams. , 2004, Physics in medicine and biology.

[7]  K Parodi,et al.  Data-driven RBE parameterization for helium ion beams , 2016, Physics in medicine and biology.

[8]  M Pugliese,et al.  Inactivation of human normal and tumour cells irradiated with low energy protons. , 2000, International journal of radiation biology.

[9]  S. España,et al.  Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver , 2011, Physics in medicine and biology.

[10]  U. Isacsson,et al.  The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer , 2005, Physics in medicine and biology.

[11]  R G Dale,et al.  The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. , 1985, The British journal of radiology.

[12]  H. Paganetti.  Relating proton treatments to photon treatments via the relative biological effectiveness-should we revise current clinical practice? , 2015, International journal of radiation oncology, biology, physics.

[13]  A. Kellerer,et al.  A generalized formulation of dual radiation action. , 2012, Radiation research.

[14]  B. Jones,et al.  The incorporation of the concept of minimum RBE (RBEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments , 2007, International journal of radiation biology.

[15]  D. Georg,et al.  Comparison of basic features of proton and helium ion pencil beams in water using GATE. , 2012, Zeitschrift fur medizinische Physik.

[16]  Anders Brahme,et al.  Recent advances in light ion radiation therapy. , 2004, International journal of radiation oncology, biology, physics.

[17]  B. Stenerlöw,et al.  Irregular variations in radiation sensitivity when the linear energy transfer is increased. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Hermann Fuchs,et al.  Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion. , 2015, Medical physics.

[19]  Mariana Guerrero,et al.  Mechanistic formulation of a lineal-quadratic-linear (LQL) model: split-dose experiments and exponentially decaying sources. , 2009, Medical physics.

[20]  J. Debus,et al.  Next generation multi-scale biophysical characterization of high precision cancer particle radiotherapy using clinical proton, helium-, carbon- and oxygen ion beams , 2016, Oncotarget.

[21]  Bengt K Lind,et al.  A model for the relative biological effectiveness of protons: The tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes , 2013, Acta oncologica.

[22]  V. Vlachoudis,et al.  The FLUKA Code: Developments and Challenges for High Energy and Medical Applications , 2014 .

[23]  M Scholz,et al.  The FLUKA Monte Carlo code coupled with the local effect model for biological calculations in carbon ion therapy , 2010, Physics in medicine and biology.

[24]  F. Kamp,et al.  Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra. , 2015, International journal of radiation oncology, biology, physics.

[25]  D T Goodhead,et al.  Direct comparison between protons and alpha-particles of the same LET: I. Irradiation methods and inactivation of asynchronous V79, HeLa and C3H 10T1/2 cells. , 1992, International journal of radiation biology.

[26]  J. Debus,et al.  9 - Experimental dosimetric comparisons at Heidelberg Ion Beam Therapy Center of 1H, 4He, 12C and 16O ion beams , 2015 .

[27]  I. Pshenichnov,et al.  Comparative study of dose distributions and cell survival fractions for 1H, 4He, 12C and 16O beams using Geant4 and Microdosimetric Kinetic model , 2014, Physics in medicine and biology.

[28]  Christian P Karger,et al.  Dosimetry for ion beam radiotherapy , 2010, Physics in medicine and biology.

[29]  G Kraft,et al.  Design and construction of a ripple filter for a smoothed depth dose distribution in conformal particle therapy. , 1999, Physics in medicine and biology.

[30]  M. Astrahan,et al.  Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation. , 2008, Medical physics.

[31]  David J. Carlson,et al.  Combined Use of Monte Carlo DNA Damage Simulations and Deterministic Repair Models to Examine Putative Mechanisms of Cell Killing , 2008, Radiation research.

[32]  R. Marchesini,et al.  Inactivation of C3H10T1/2 cells by low energy protons and deuterons. , 1998, International journal of radiation biology.

[33]  Sandro Rossi,et al.  The National Centre for Oncological Hadrontherapy (CNAO): Status and perspectives. , 2015, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[34]  Tatsuaki Kanai,et al.  Microdosimetric Measurements and Estimation of Human Cell Survival for Heavy-Ion Beams , 2006, Radiation research.

[35]  O Jäkel,et al.  A system for three-dimensional dosimetric verification of treatment plans in intensity-modulated radiotherapy with heavy ions. , 1999, Medical physics.

[36]  H Paganetti,et al.  Elevated LET components in clinical proton beams , 2011, Physics in medicine and biology.

[37]  O Jäkel,et al.  The Heidelberg Ion Therapy Center. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer , 2014, Physics in medicine and biology.

[39]  M. Durante,et al.  Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation , 2012, Journal of radiation research.

[40]  K M Prise,et al.  Inactivation of V79 cells by low-energy protons, deuterons and helium-3 ions. , 1996, International journal of radiation biology.

[41]  A motorized solid-state phantom for patient-specific dose verification in ion beam radiotherapy. , 2015, Physics in medicine and biology.

[42]  Aimee L. McNamara,et al.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data , 2015, Physics in medicine and biology.

[43]  Marco Zaider,et al.  Microdosimetry and Its Applications , 1995 .

[44]  P. Karaiskos,et al.  Dose and dose averaged LET comparison of ¹H, ⁴He, ⁶Li, ⁸Be, ¹⁰B, ¹²C, ¹⁴N, and ¹⁶O ion beams forming a spread-out Bragg peak. , 2011, Medical physics.

[45]  Harald Paganetti,et al.  Extension of TOPAS for the simulation of proton radiation effects considering molecular and cellular endpoints , 2015, Physics in medicine and biology.

[46]  E. Blakely,et al.  Radiobiological characterization of the inactivating events produced in mammalian cells by helium and heavy ions. , 1977, International journal of radiation oncology, biology, physics.

[47]  M Zaider,et al.  The synergistic effects of different radiations. , 1980, Radiation research.

[48]  I. Toma-Dasu,et al.  Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans. , 2014, Medical physics.

[49]  R. Hawkins.  A microdosimetric-kinetic theory of the dependence of the RBE for cell death on LET. , 1998, Medical physics.

[50]  F Ianzini,et al.  RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facility. , 1998, International journal of radiation biology.

[51]  J. Quivey,et al.  Clinical experience and expectations with helium and heavy ion irradiation. , 1977, International journal of radiation oncology, biology, physics.

[52]  Lech Papiez,et al.  Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[53]  Katia Parodi,et al.  Helium ions for radiotherapy? Physical and biological verifications of a novel treatment modality. , 2016, Medical physics.

[54]  G. Moschini,et al.  RBE-LET relationship for the survival of V79 cells irradiated with low energy protons. , 1989, International journal of radiation biology.

[55]  R. Hawkins.  A statistical theory of cell killing by radiation of varying linear energy transfer. , 1994, Radiation research.

[56]  R. Dale,et al.  The assessment of RBE effects using the concept of biologically effective dose. , 1999, International journal of radiation oncology, biology, physics.

[57]  Michael Scholz,et al.  Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning. , 2010, International journal of radiation oncology, biology, physics.

[58]  K. Parodi,et al.  A Monte Carlo-based treatment-planning tool for ion beam therapy , 2013, Journal of radiation research.

[59]  R. Stewart,et al.  Effects of Radiation Quality and Oxygen on Clustered DNA Lesions and Cell Death , 2011, Radiation research.